Instead of its usual untitled letter, the FDA's Office of Prescription Drug Promotion (OPDP) stepped it up a notch in sending a warning letter to Shionogi Inc., of Florham Park, N.J., part of Shionogi & Co. Ltd., citing issues with a patient co-pay assistance voucher for the company's head lice lotion Ulesfia (benzyl alcohol).